Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Breast Cancer Liquid Biopsy Trial

for
Breast Cancer, Cancer
Location: Bronx NY, New York NY, Hollywood FL, Orlando FL,
Sponsor: Anthony Magliocco

Sex: All

Age: 18+

Code: NCT04962529

Recruiting

Calgary Registry for Advanced and Therapeutic Endoscopy

for
Biliary Disease, Pancreatic Diseases
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT04259580

Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

for
Malignant Solid Tumors
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT02421380

Recruiting

Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.

for
Sarcoid, Cardiovascular Diseases, Cancer
Location: Boston MA
Sponsor: Ralph Weissleder, MD

Sex: All

Age: 18 - 70+

Code: NCT04843891

Phase 1, Recruiting

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

for
Diabetes, Cancer, Multiple Sclerosis, Arthritis,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT02777060

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase 1, Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: The Bronx NY, Fairfax VA, Orlando FL, Atlanta GA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase 1, Recruiting

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

for
Cancer, Occupational Therapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06329531

Recruiting

Comprehensive Outcomes for After Cancer Health

for
Ovarian Cancer, Breast Cancer, Lung Cancer, Gastric Cancer,
Location: Boston MA, Houston TX
Sponsor: Pack Health

Sex: All

Age: 18+

Code: NCT05349227

Recruiting

Pilot Trial of Spiritual Care Interventions for Patients With Cancer

for
Advanced Cancer
Location: Brooklyn NY, Galveston TX
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06811376

Recruiting

A Study of EBC-129 in Advanced Solid Tumours

for
Advanced Solid Tumours
Location: Houston TX, Aurora CO
Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities

Sex: All

Age: 18+

Code: NCT05701527

Phase 1, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Boston MA, Mineola NY, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase 1, Recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

for
Advanced Cancer, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05663710

Phase 1, Phase 2, Recruiting

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

for
Metastatic Malignant Neoplasm in the Bone,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06549478

Phase 1, Recruiting

Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

for
Pediatric Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT07288476

Recruiting

Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

for
Chronic Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07733141

Recruiting

Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors

for
Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC
Sponsor: Adriana Fonseca

Sex: All

Age: 0 - 45

Code: NCT07851636

Recruiting

A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.

for
Ovarian Cancer, Advanced Malignant Solid Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07389239

Phase 1, Phase 2, Recruiting

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

for
Advanced Cancer, Pain
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 21+

Code: NCT06117709

Recruiting

Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07673614

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial